These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17897566)

  • 21. The RACE study in perspective of randomized studies on management of persistent atrial fibrillation.
    Hagens VE; Van Gelder IC; Crijns HJ;
    Card Electrophysiol Rev; 2003 Jun; 7(2):118-21. PubMed ID: 14618033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cardioversion efficacy of nifekalan in patients with sustained atrial fibrillation after radiofrequency ablation].
    Li F; Xia Z; Yu JH; Chen Q; Hu JZ; Zhu B; Xia ZR; Huang QH; Li JX; Hong K; Wu YQ; Cheng XS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Dec; 47(12):963-968. PubMed ID: 31877591
    [No Abstract]   [Full Text] [Related]  

  • 23. Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation).
    Camm AJ; Breithardt G; Crijns H; Dorian P; Kowey P; Le Heuzey JY; Merioua I; Pedrazzini L; Prystowsky EN; Schwartz PJ; Torp-Pedersen C; Weintraub W
    J Am Coll Cardiol; 2011 Jul; 58(5):493-501. PubMed ID: 21777747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized Study of Persistent Atrial Fibrillation Ablation: Ablate in Sinus Rhythm Versus Ablate Complex-Fractionated Atrial Electrograms in Atrial Fibrillation.
    Bassiouny M; Saliba W; Hussein A; Rickard J; Diab M; Aman W; Dresing T; Callahan T; Bhargava M; Martin DO; Shao M; Baranowski B; Tarakji K; Tchou PJ; Hakim A; Kanj M; Lindsay B; Wazni O
    Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003596. PubMed ID: 26857909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of rhythm control in persistent or permanent atrial fibrillation with overdrive atrial pacing and antiarrhythmic drugs after linear right atrial catheter ablation.
    Filipecki A; Saksena S; Lin WH
    Am J Cardiol; 2003 Nov; 92(9):1037-44. PubMed ID: 14583353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do we need pharmacological therapy for atrial fibrillation in the ablation era?
    Lévy S
    J Interv Card Electrophysiol; 2006 Dec; 17(3):189-94. PubMed ID: 17340189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary Vein Isolation Alone Versus Additional Linear Ablation in Patients With Persistent Atrial Fibrillation Converted to Paroxysmal Type With Antiarrhythmic Drug Therapy: A Multicenter, Prospective, Randomized Study.
    Yu HT; Shim J; Park J; Kim IS; Kim TH; Uhm JS; Joung B; Lee MH; Kim YH; Pak HN
    Circ Arrhythm Electrophysiol; 2017 Jun; 10(6):. PubMed ID: 28611206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
    Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial.
    Kirchhof P; Breithardt G; Camm AJ; Crijns HJ; Kuck KH; Vardas P; Wegscheider K
    Am Heart J; 2013 Sep; 166(3):442-8. PubMed ID: 24016492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term rhythm control of drug-refractory atrial fibrillation with "hybrid therapy" incorporating dual-site right atrial pacing, antiarrhythmic drugs, and right atrial ablation.
    Madan N; Saksena S
    Am J Cardiol; 2004 Mar; 93(5):569-75. PubMed ID: 14996581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of practice patterns in the treatment of atrial fibrillation among the commercially insured.
    Liu J; Sylwestrzak G; Barron J; Rosenberg A; White J; Whitney J; Redberg R; Malenka D
    Curr Med Res Opin; 2014 Sep; 30(9):1707-13. PubMed ID: 24809834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonpharmacologic strategies for treating atrial fibrillation.
    Lüderitz B; Pfeiffer D; Tebbenjohanns J; Jung W
    Am J Cardiol; 1996 Jan; 77(3):45A-52A. PubMed ID: 8607391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Present concepts in management of atrial fibrillation: From drug therapy to ablation.
    Forleo GB; Santini L; Romeo F
    World J Cardiol; 2009 Dec; 1(1):11-22. PubMed ID: 21160571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic management of atrial fibrillation: current therapeutic strategies.
    Lévy S
    Am Heart J; 2001 Feb; 141(2 Suppl):S15-21. PubMed ID: 11174354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation.
    Schweizer PA; Becker R; Katus HA; Thomas D
    Drug Des Devel Ther; 2011 Jan; 5():27-39. PubMed ID: 21267357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin receptor blocker as adjunctive therapy for rhythm control in atrial fibrillation: results of the irbesartan-amiodarone trial.
    Madrid AH; Escobar C; Rebollo JM; Marín I; Bernal E; Nannini S; Limón L; Peng J; Moro C
    Card Electrophysiol Rev; 2003 Sep; 7(3):243-6. PubMed ID: 14739722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of timing in treatment of atrial fibrillation: An AFFIRM substudy.
    Yang E; Tang O; Metkus T; Berger RD; Spragg DD; Calkins HG; Marine JE
    Heart Rhythm; 2021 May; 18(5):674-681. PubMed ID: 33383228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrial fibrillation and stroke: the evolving role of rhythm control.
    Patel TK; Passman RS
    Curr Treat Options Cardiovasc Med; 2013 Jun; 15(3):299-312. PubMed ID: 23397289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological management of atrial fibrillation: one, none, one hundred thousand.
    Lucà F; La Meir M; Rao CM; Parise O; Vasquez L; Carella R; Lorusso R; Daniela B; Maessen J; Gensini GF; Gelsomino S
    Cardiol Res Pract; 2011 Apr; 2011():874802. PubMed ID: 21577272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.